In country vs offshoring: The benefits of keeping production in the US vs overseas

Now Live: Presentation Replay from BIO 2025 in Boston. At BIO 2025, our Chief Quality Officer, Sundar Ramanan, PhD, MBA, took the stage at the BioProcess International Theatre to explore a critical industry question: Is local production in the U.S. the key to faster, more resilient biologics supply chains—or do global operations still lead on scale and cost?

In this compelling presentation, Dr. Ramanan unpacks:
✅ Trade-offs between in-country and offshore manufacturing
✅ How to maintain quality and compliance across borders
✅ Why Enzene’s hybrid model is designed to deliver speed, flexibility, and cost-efficiency